Merck tests new Drug's safety on healthy volunteers
NCT ID NCT07266818
Summary
This early-stage study aims to check the safety and side effects of an experimental drug called MK-1167 in healthy adults. It will involve about 30 healthy volunteers and will closely monitor how their bodies react to the drug, including its effect on heart rhythm. The main goal is to gather basic safety information before testing the drug in people with a specific disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hassman Research Institute Marlton Site ( Site 0001)
Marlton, New Jersey, 08053, United States
Conditions
Explore the condition pages connected to this study.